Alan J Russell insider trades: Edgewise Therapeutics (EWTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX | ↓ Sell | 5,901 | $43.73 | $258K | Direct | Aug 14, 2026 (2d) |
| Jul 1, 2026 | EWTX | ↓ Sell | 200,000 | $39.41 | $7.9M | Direct | Jul 2, 2026 (1d) |
| Nov 12, 2025 | EWTX | ↓ Sell | 100,000 | $21.12 | $2.1M | Direct | Nov 13, 2025 (1d) |
| Aug 26, 2025 | EWTX | ↓ Sell | 100,000 | $14.60 | $1.5M | Direct | Aug 28, 2025 (2d) |
| Aug 12, 2025 | EWTX | ↓ Sell | 1,907 | $13.39 | $26K | Direct | Aug 14, 2025 (2d) |
| May 2, 2025 | EWTX | ↓ Sell | 1,551 | $16.45 | $26K | Direct | May 7, 2025 (5d) |
| Mar 7, 2025 | EWTX | ↓ Sell | 200 | $30.02 | $6K | Direct | Mar 11, 2025 (4d) |
| Feb 6, 2025 | EWTX | ↓ Sell | 9,215 | $30.04 | $277K | Direct | Feb 7, 2025 (1d) |
| Dec 30, 2024 | EWTX | ↓ Sell | 100,000 | $27.37 | $2.7M | Direct | Dec 31, 2024 (1d) |
| Sep 20, 2024 | EWTX | ↓ Sell | 75,000 | $28.27 | $2.1M | Direct | Sep 24, 2024 (4d) |
| May 2, 2024 | EWTX | ↓ Sell | 1,576 | $18.91 | $30K | Direct | May 3, 2024 (1d) |
| Dec 26, 2023 | EWTX | ↓ Sell | 172,585 | $9.33 | $1.6M | Direct | Dec 28, 2023 (2d) |
| May 2, 2023 | EWTX | ↓ Sell | 1,602 | $8.90 | $14K | Direct | May 3, 2023 (1d) |
| Nov 15, 2021 | EWTX | ↓ Sell | 479 | $19.11 | $9K | Direct | Nov 17, 2021 (2d) |
| Nov 12, 2021 | EWTX | ↓ Sell | 69,740 | $19.91 | $1.4M | Direct | Nov 12, 2021 (0d) |
| Nov 8, 2021 | EWTX | ↓ Sell | 29,451 | $19.82 | $584K | Direct | Nov 8, 2021 (0d) |
| Nov 3, 2021 | EWTX | ↓ Sell | 44,172 | $17.88 | $790K | Direct | Nov 3, 2021 (0d) |
| Oct 15, 2021 | EWTX | ↓ Sell | 7,182 | $18.17 | $130K | Direct | Oct 18, 2021 (3d) |
| Oct 11, 2021 | EWTX | ↓ Sell | 1,270 | $18.02 | $23K | Direct | Oct 13, 2021 (2d) |
| Oct 8, 2021 | EWTX | ↓ Sell | 21,028 | $18.39 | $387K | Direct | Oct 8, 2021 (0d) |
| Oct 5, 2021 | EWTX | ↓ Sell | 5,778 | $18.24 | $105K | Direct | Oct 5, 2021 (0d) |
| Sep 29, 2021 | EWTX | ↓ Sell | 26,454 | $17.10 | $452K | Direct | Sep 30, 2021 (1d) |
| Sep 27, 2021 | EWTX | ↓ Sell | 58,546 | $18.30 | $1.1M | Direct | Sep 27, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EWTX insiders
Open-market trades in the last 12 months
About Alan J Russell's insider trades
Alan J Russell is Chief Scientific Officer at Edgewise Therapeutics (EWTX). Since Sep 27, 2021, Alan has reported no open-market purchases and 23 sales worth $23.5M on SEC Form 4. In the last 12 months: 3 sales ($10.3M).
Their filings also include option exercises (13 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EWTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.